Introducing WELL Research
Established clinical research expertise, strengthened by the WELL Health ecosystem.
Clinical research exists to improve health outcomes, but progress depends on finding and enrolling the right trial participants. For clinical trial sponsors, recruitment can be slow, costly and difficult to predict.
As the clinical research brand of WELL Health, WELL Research brings together the capabilities needed to assess feasibility, recruit trial participants and deliver studies, connecting clinical research more closely to the care patients already receive.
BioPharma Services
20 years of clinical research operations
WELL Health ecosystem
Scale, relationships, consent and technology
WELL Research
Integrated recruitment and study delivery
The WELL Research Platform
One platform for feasibility, recruitment and study delivery.
At WELL Research, we believe clinical trials can be a specialized form of care and, in the right setting, offer some patients access to an innovative therapy that may be the most valuable option available to them. Our platform brings together the capabilities needed to assess feasibility, recruit trial participants and deliver studies.
Recruitment
Through WELLTrust, we enable motivated patients to join a community of Canadians who have explicitly consented to hear about clinical trial opportunities. Existing WELL clinic and provider relationships give outreach a trusted starting point. Our teams coordinate outreach and screening, reducing reliance on individual providers to drive recruitment, so providers can remain focused on patient care.
Matching
Express consent provides the foundation for focused patient identification. Working with HEALWELL AI and its DARWEN™ platform, we are developing technology-enabled feasibility and protocol-to-patient matching to identify potential candidates. Formal screening determines eligibility.
Delivery
Our full-service CRO supports early-phase trials, our Site Management Organization (SMO) supports late-stage studies today, and our bioanalysis lab operates across trial phases, disease indications and therapeutic modalities. The SMO model is intended to extend delivery into selected WELL Clinics, while WELL’s diagnostics network can create specialty recruitment pathways.
Together, these capabilities support feasibility, participant recruitment and study delivery, connecting clinical trials more closely to the care patients already receive.
What WELL Adds
A connected healthcare ecosystem at scale.
WELL’s healthcare ecosystem provides the clinic and provider reach, trusted patient relationships and consent foundation that strengthen the established clinical research platform.
WELL Health Clinic Network
Canada’s largest outpatient network, supporting 5M+ patient visits per year.
WELLSTAR Provider Network
Healthcare practitioners connected through WELLSTAR’s network.
WELLTrust Consent Platform
Patients consented to participate in clinical trials, with a target of 250K by the end of 2026.
HEALWELL AI
DARWEN™
AI-enabled feasibility assessment and protocol-to-patient matching for clinical trial recruitment.
We communicate only within the scope of each patient’s consent. Patients decide whether to learn more about or participate in a trial. Participation is voluntary, and consent can be withdrawn at any time without affecting their care.
Our Promise
Trial Recruitment Solved
For sponsors, this integrated model provides a faster, highly dependable approach to trial recruitment and study delivery through one partner. For participants, it offers a relevant and respectful way to learn about and engage in clinical trials, grounded in consent and connected to their care. This approach helps advance discoveries that can lead to better health outcomes.
Until the full WELL Research website launches, current clinical research service information remains available through BioPharma Services.